Efficacy and Tolerability of Capmatinib in a Very Elderly Patient with Metastatic NSCLC Harboring a MET Exon 14 Mutation.
PERSONALIZED MEDICINE（2024）
关键词
capmatinib,elderly,MET exon 14 skipping mutation,MET tyrosine kinase inhibitors,NSCLC
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要